Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Mauri

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Clinical Practice and Epidemiology in Mental Health : CP & EMH|March 25, 2006
Substance abuse in first-episode schizophrenic patients: a retrospective studyM C Mauri, L S Volonteri, I F De Gaspari, et al.
Human Psychopharmacology|November 21, 2012
Safety of SSRIs during pregnancy: a controlled studyA C Altamura, I F De Gaspari, C Rovera, et al.
L'Encephale|February 24, 2001
"Postpsychotic depression" and residual schizophrenia in a mental health hospitalM C Mauri, V Laini, R Barone, et al.
Psychiatry Research|May 14, 1998
Cholecystokinin, beta-endorphin and vasoactive intestinal peptide in peripheral blood mononuclear cells of drug-naive schizophrenic patients treated with haloperidol compared to healthy controlsM C Mauri, R Rudelli, S Vanni, et al.
Neuropsychobiology|October 5, 2001
Predictive value of amino acids in the treatment of major depression with fluvoxamineM C Mauri, L Boscati, L S Volonteri, et al.
Clinical Drug Investigation|August 13, 2016
Gabapentin and the Prophylaxis of Bipolar Disorders in Patients Intolerant to LithiumM C Mauri, V Laini, M E Scalvini, et al.
Pharmacopsychiatry|June 2, 2007
Ziprasidone outcome and tolerability: a practical clinical trial with plasma drug levelsM C Mauri, A Colasanti, M Rossattini, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 12, 2005
Clinical outcome and olanzapine plasma levels in acute schizophreniaM C Mauri, C P C Steinhilber, R Marino, et al.
Journal of Psychopharmacology (Oxford, England)|May 2, 2009
Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levelsL S Volonteri, A Colasanti, G Cerveri, et al.
Psychopharmacology|January 1, 1988
Trazodone in late life depressive states: a double-blind multicenter study versus amitriptyline and mianserinA C Altamura, M C Mauri, F Colacurcio, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Clinical Practice and Epidemiology in Mental Health : CP & EMH|March 25, 2006
Substance abuse in first-episode schizophrenic patients: a retrospective studyM C Mauri, L S Volonteri, I F De Gaspari, et al.
Human Psychopharmacology|November 21, 2012
Safety of SSRIs during pregnancy: a controlled studyA C Altamura, I F De Gaspari, C Rovera, et al.
L'Encephale|February 24, 2001
"Postpsychotic depression" and residual schizophrenia in a mental health hospitalM C Mauri, V Laini, R Barone, et al.
Psychiatry Research|May 14, 1998
Cholecystokinin, beta-endorphin and vasoactive intestinal peptide in peripheral blood mononuclear cells of drug-naive schizophrenic patients treated with haloperidol compared to healthy controlsM C Mauri, R Rudelli, S Vanni, et al.
Neuropsychobiology|October 5, 2001
Predictive value of amino acids in the treatment of major depression with fluvoxamineM C Mauri, L Boscati, L S Volonteri, et al.
Clinical Drug Investigation|August 13, 2016
Gabapentin and the Prophylaxis of Bipolar Disorders in Patients Intolerant to LithiumM C Mauri, V Laini, M E Scalvini, et al.
Pharmacopsychiatry|June 2, 2007
Ziprasidone outcome and tolerability: a practical clinical trial with plasma drug levelsM C Mauri, A Colasanti, M Rossattini, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 12, 2005
Clinical outcome and olanzapine plasma levels in acute schizophreniaM C Mauri, C P C Steinhilber, R Marino, et al.
Journal of Psychopharmacology (Oxford, England)|May 2, 2009
Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levelsL S Volonteri, A Colasanti, G Cerveri, et al.
Psychopharmacology|January 1, 1988
Trazodone in late life depressive states: a double-blind multicenter study versus amitriptyline and mianserinA C Altamura, M C Mauri, F Colacurcio, et al.
Pageof 6